| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | RSV Fusion Protein |
|---|
| Clone | RSHZ19 (Felvizumab) |
|---|
| Host Species | Rabbit |
|---|
| Reactive Species | n/a |
|---|
| Isotype | IgG kappa |
|---|
| Format | Protein A purified |
|---|
| Size | 0.2 mg |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA, Functional. Though shown to be safe and well-tolerated (Everitt, 1996) and protective against RSV infection in BALB/c mice and cotton rats (Wyde, 1995), this antibody did not demonstrate efficacy in a Phase 3 study (Reichert, 2008). In in vitro studies, palivizumab, another humanized Mab specific for the F protein of RSV, was 4 to 5-fold more potent than felvizumab in neutralising RSV (Scott, 1999). |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | The RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) from Novus Biologicals is a rabbit monoclonal antibody to RSV Fusion Protein. This antibody reacts with virus. The RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) has been validated for the following applications: ELISA, Functional. This antibody is specific for the conserved fusion (F) protein of RSV |
|---|
| Immunogen | This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework. Specificity: This antibody is specific for the conserved fusion (F) protein of RSV. |
|---|
| Other Names | n/a |
|---|
| Gene, Accession # | n/a |
|---|
| Catalog # | NBP2-75191 |
|---|
| Price | |
|---|
| Order / More Info | RSV Fusion Protein Antibody from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|